Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227,306,614
-
Total 13F shares
-
58,353,019
-
Share change
-
+1,001,835
-
Total reported value
-
$506,516,748
-
Put/Call ratio
-
37%
-
Price per share
-
$8.68
-
Number of holders
-
131
-
Value change
-
+$4,617,599
-
Number of buys
-
68
-
Number of sells
-
53
Institutional Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q1 2022
As of 31 Mar 2022,
Gossamer Bio, Inc. - Common Stock (GOSS) was held by
131 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,353,019 shares.
The largest 10 holders included
HHLR ADVISORS, LTD., VANGUARD GROUP INC, BlackRock Inc., FEDERATED HERMES, INC., STATE STREET CORP, Omega Fund Management, LLC, Octagon Capital Advisors LP, BOXER CAPITAL, LLC, Artal Group S.A., and CITADEL ADVISORS LLC.
This page lists
132
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.